GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Selling, General, & Admin. Expense

Touyun Biotech Group (HKSE:01332) Selling, General, & Admin. Expense : HK$141.7 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Selling, General, & Admin. Expense?

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Touyun Biotech Group's selling, general, & admin. expense for the six months ended in Dec. 2023 was HK$70.8 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2023 was HK$141.7 Mil.


Touyun Biotech Group Selling, General, & Admin. Expense Historical Data

The historical data trend for Touyun Biotech Group's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Selling, General, & Admin. Expense Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 158.52 139.20 144.74 154.68 141.71

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.87 75.28 79.40 70.95 70.77

Competitive Comparison of Touyun Biotech Group's Selling, General, & Admin. Expense

For the Packaging & Containers subindustry, Touyun Biotech Group's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group's Selling, General, & Admin. Expense Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Selling, General, & Admin. Expense falls into.



Touyun Biotech Group Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$141.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group  (HKSE:01332) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Touyun Biotech Group Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.
Executives
Wang Liang 2101 Beneficial owner
Tian Yuze 2101 Beneficial owner
Tian Yuze 2101 Beneficial owner
Qiao Yanfeng 2201 Interest of corporation controlled by you
Qin Fen 2101 Beneficial owner

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines